Cost-effectiveness of the Single-implant Mandibular Overdenture Versus Mandibular Conventional Denture

Sponsor
Universidade Federal de Goias (Other)
Overall Status
Completed
CT.gov ID
NCT03463174
Collaborator
Conselho Nacional de Desenvolvimento Científico e Tecnológico (Other)
80
1
2
31.7
2.5

Study Details

Study Description

Brief Summary

This is a randomized clinical trial designed to assess the 1-year effectiveness of two treatment modalities for the mandibular edentulists: conventional complete dentures and single-implant mandibular overdenture.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Mandibular overdenture
  • Other: Mandibular complete denture
N/A

Detailed Description

This randomized clinical trial alongside a cost-effectiveness analysis will include edentulous individuals who meet eligibility criteria. New maxillary and mandibular dentures will be fabricated for all participants following a standardized protocol. Then, participants will be randomized into one of the treatment groups: conventional complete denture group or single-implant mandibular overdenture group. Each participant allocated to the overdenture group will then receive an implant (Titamax TI cortical - Neodent, Brazil) in the mandibular midline followed by the immediate connection of an O-Ring/ball attachment with intra-oral incorporation of the retention system in the mandibular denture. Direct costs related to therapies in both groups will be identified, measured and valuated for one year after treatment and patient-reported outcomes will be assessed. Incremental cost-effectiveness ratios will be estimated and graphically presented on cost-effectiveness planes. A Markov decision tree will be constructed to set out the consequences of the competing alternatives. Sensitivity analysis on the most important assumptions will be performed in order to assess the robustness of the model.

Study Design

Study Type:
Interventional
Actual Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Randomized Controlled Clinical Trial Alongside a Cost-effectiveness Analysis of the Mandibular Conventional Complete Denture Versus Single-implant Mandibular Overdenture
Actual Study Start Date :
Mar 10, 2015
Actual Primary Completion Date :
Sep 20, 2017
Actual Study Completion Date :
Oct 31, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Single-implant mandibular overdenture

Participants allocated to this group will have a dental implant placed in the mandibular midline followed by the immediately insertion of a ball attachment and the incorporation of a retention matrix to the mandibular denture.

Procedure: Mandibular overdenture
Placement of an implant in the mandibular midline.
Other Names:
  • Dental Implant (Straumann StandardPlus SLActive® RN implant)
  • Active Comparator: Mandibular complete denture

    Participants allocated to this group will not receive any additional treatment besides the new set of conventional complete dentures. When needed, retreatment or any adjustment/repair in the dentures will be performed accordingly. Participants will receive regular maintenance for their dentures, including adjustments for the elimination of sore areas, denture relining and repair of fractures, when needed, until the end of the follow-up period.

    Other: Mandibular complete denture
    No intervention.
    Other Names:
  • Complete denture
  • Outcome Measures

    Primary Outcome Measures

    1. Oral health-related quality of life (OHRQoL) [From baseline to 12 months after the intervention]

      The cross-culturally adapted Brazilian version of the Oral Health Impact Profile for edentulous subjects (OHIP-EDENT) will be used. It contains 19 items divided in four different subscale domains: (I) masticatory discomfort and disability (four items), (II) psychological discomfort and disability (five items), (III) social disability (five items), and (IV) oral pain and discomfort (five items). The items are answerable by a 3-point Likert scale and responses will be summed to result an overall score. Higher scores represent worse OHRQoL.

    Secondary Outcome Measures

    1. Satisfaction with the dentures [From baseline to 12 months after the intervention]

      Participants will report how satisfied they are on a 0-100 scale by choosing a multiple of 10. Zero will be considered the least satisfied possible and "100" the most satisfied possible.

    Other Outcome Measures

    1. Costs [From denture's fabrication to 12 months after the intervention]

      All the direct dental costs related to the clinical and laboratory phases of both treatment groups will be listed, measured and valued.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • To present favorable general health and the need to be rehabilitated with a new set of complete dentures

    • To agree to be randomly assigned to one of the two study groups

    • To be able to comprehend and answer the data collection instruments.

    Exclusion Criteria:
    • Presence of general health conditions that may contraindicate implant surgery (such as uncontrolled type II diabetes mellitus or uncontrolled cardiovascular conditions)

    • Insufficient height and volume in the midline region to receive an implant of at least 3.75mm x 9.0mm

    • Presence of evident signs of cognitive impairment and/or oral conditions requiring additional treatments, such as oral lesions and temporomandibular disorders

    • Inability to attend to the scheduled appointments and follow-up visits

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 School of Dentistry, Federal University of Goias Goiânia Goias Brazil 74605-220

    Sponsors and Collaborators

    • Universidade Federal de Goias
    • Conselho Nacional de Desenvolvimento Científico e Tecnológico

    Investigators

    • Study Director: Claudio R Leles, DDS, PhD, Universidade Federal de Goias

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Cláudio Rodrigues Leles, Associate professor, Universidade Federal de Goias
    ClinicalTrials.gov Identifier:
    NCT03463174
    Other Study ID Numbers:
    • UFG_020_12
    First Posted:
    Mar 13, 2018
    Last Update Posted:
    Mar 13, 2018
    Last Verified:
    Mar 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Cláudio Rodrigues Leles, Associate professor, Universidade Federal de Goias
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 13, 2018